Key result
Developing depressive symptoms in later life was associated with significant decline in global cognition (b = -0.04, P<0.001), attention, and executive function compared to non-depressed adults.
Why the study?
Depression and vascular disease can both be risk factors for cognitive decline, but whether vascular disease indicators associate with depression over time and whether depression associates with cognition independent of vascular disease remained unclear.
Are indicators of vascular disease associated with depression over time, and is depression associated with cognition independent of vascular disease in older adults?
Cohort (n=1,032)
Are indicators of vascular disease associated with depression over time, and is depression associated with cognition independent of vascular disease in older adults?
Effect estimate: b = -0.04
p-value: p=<0.001
Late-life depression and cognitive decline appear to evolve in tandem independent of cerebrovascular disease markers, highlighting the importance of early identification and treatment of depression in older adults.
Late-life depressive symptoms may signal higher cognitive decline risk independent of vascular markers; leaves open whether treating depression preserves cognition.
Depression and vascular disease can both be risk factors for cognitive decline. This study assessed whether indicators of vascular disease are associated with depression over time, and whether depression is associated with cognition independent of vascular disease. Participants were 1032 community-dwelling, older adults from the Sydney Memory and Ageing Study. Depressive symptoms were measured on the 15-item Geriatric Depression Scale, and depression trajectories were classified using latent class growth modelling. Global cognition and individual cognitive domains were assessed. Indicators of vascular disease were history of stroke or transient ischaemic attack (TIA) and total white matter hyperintensities (TWMH). Generalised linear mixed modelling assessed whether vascular markers were associated with change in depressive symptoms over time. Linear mixed modelling examined relationships between depression, vascular disease indicators, and cognition. History of stroke/TIA or TWMH did not predict depression over time ( p = 0.11 and p = 0.70). Baseline stroke/TIA history was associated with a decline in attention over time (b = −0.05, p = 0.04). Significant differences between latent depression trajectories classes in cognitive decline were observed, with participants who became depressed over time experiencing decline in global cognition (b = −0.04, p < 0.001), attention (b = −0.05, p < 0.001) and executive function (b = −0.05, p < 0.001), compared to the non-depressed group. Our findings suggest that depression in later life may not precede cognitive decline. Instead, depressive symptoms and cognitive decline, particularly in attention and executive function, may evolve in tandem over time. This reinforces the importance of early identification and treatment of depression in older adults to potentially mitigate cognitive deterioration. • Older adults with depressive symptoms at baseline had lower global cognition at baseline as compared to others. • Older adults who developed depressive symptoms in later life had significantly greater decline in executive function. • Across all models, the relationship between depression and cognition over time was unaffected by markers of vascular disease. • Depression and cognitive decline in older adults may share biological processes affecting neuropsychiatric symptoms
No takes yet. Share an insight, caveat, or question.
Loyal et al. (2025) conducted a cohort in Depression and cognitive decline (n=1,032). Depressive symptoms vs. Non-depressed group was evaluated on Decline in global cognition (b = -0.04, p=<0.001). Developing depressive symptoms in later life was associated with significant decline in global cognition (b = -0.04, P<0.001), attention, and executive function compared to non-depressed adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: